2025 HCPCS Code C9142
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Notice | HCPCS C9142 terminated on December 31, 2022. |
Short Description | Inj, alymsys, 10 mg |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | October 01, 2022 |
HCPCS Action Effective Date | January 01, 2023 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9066 - Sacituzumab govitecan-hziy
- C9067 - Gallium ga-68 dotatoc
- C9068 - Copper cu-64, dotatate, dx
- C9069 - Belantamab mafodontin-blmf
- C9070 - Injection, tafasitamab-cxix
- C9071 - Injection, viltolarsen
- C9072 - Inj, imm glob asceniv
- C9073 - Brexucabtagene autoleucel ca
- C9074 - Injection, lumasiran
- C9075 - Injection, casimersen, 10 mg
- C9076 - Lisocabtagene car pos t
- C9077 - Inj cabotegravir/rilpivirine
- C9078 - Inj, trilaciclib, 1 mg
- C9079 - Inj, evinacumab-dgnb, 5 mg
- C9080 - Inj, melphalan flufen, 1 mg
- C9081 - Idecabtagene car pos t
- C9082 - Inj dostarlimab-gxly, 100 mg
- C9083 - Inj, amivantamab-vmjw, 10 mg
- C9084 - Loncastuximab-lpyl, 0.1 mg
- C9085 - Inj avalglucosid alfa-ngpt